Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.734
4.11 %
$ 4.07 M
Market Cap
-0.27
P/E
INCOME STATEMENT
34.1 M
REVENUE
-22.7 M
OPERATING INCOME
-20.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Biofrontera Inc.
| Revenue | 34.1 M |
| Cost Of Revenue | 17.4 M |
| Gross Profit | 16.6 M |
| Operating Expenses | 40 M |
| Operating Income | -22.7 M |
| Other Expenses | -2.55 M |
| Net Income | -20.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 34.1 | 28.7 | 24.1 | 18.8 | 26.2 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 17.4 | 15.2 | 12.7 | 9.1 | 12.4 |
| Gross Profit | 16.6 | 13.5 | 11.4 | 9.8 | 13.8 |
| OPERATING INCOME | |||||
| Operating Expenses | 40.0 | 35.9 | 37.2 | 18.1 | 28.7 |
| Selling, General and Administrative Expenses | 39.1 | 35.9 | 37.2 | 18.1 | 28.7 |
| Research and Development Expenses | 77 K | 0 | 0 | 0 | 0 |
| Operating Income | (22.7) | (22.4) | (25.9) | (8.3) | (14.9) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0.6 | 0.2 | 0.3 | 2.9 | 2.2 |
| Total Other Income | 2.6 | 18.0 | (12.5) | (2.6) | 4.0 |
| Pre-Tax Income | (20.1) | (0.6) | (37.7) | (10.9) | (10.9) |
| NET INCOME | |||||
| Tax Provision | 14 K | 32 K | 56 K | 64 K | 33 K |
| Net Income | (20.1) | (0.6) | (37.7) | (11.0) | (11.0) |
| EPS | 13 | 0.61 | 44.1 | 18.9 | 18.1 |